Therapy Areas: Hereditary Disorders
12 January 2018 - - Boston, Massachusetts-based serious disease therapeutics developer Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) has received from the European Commission an extension of the marketin...
4 January 2018 - - US-based developer of glycopolymer-based therapeutics for pulmonary disease Synspira has received up to a USD 3m award from the Cystic Fibrosis Foundation to advance clinical develo...
21 December 2017 - Biopharmaceutical startup JHL Biotech (Stock Code:6540.TWO) disclosed on Wednesday that it has filed a Phase 1 Clinical Trial Application with the Dutch Healthcare Authority for its...
8 December 2017 - - Boston, Massachusetts-based serious disease therapeutics developer Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) has released positive results from an open-label Phase 3 study of Kaly...
4 December 2017 - - A meeting of the Antimicrobial Drugs Advisory Committee of the US Food and Drug Administration has been scheduled for January 11, 2018 to review Hayward, California-based respirato...
28 November 2017 - A new study from the University of Copenhagen has indicated that an active sulphurous compound found in garlic can fight against robust bacteria in patients with chronic infections,...